Review
doi: 10.1038/nrc1565.
The promise of genetically engineered mice for cancer prevention studies
Affiliations
- PMID: 15738982
- DOI: 10.1038/nrc1565
Item in Clipboard
Review
The promise of genetically engineered mice for cancer prevention studies
Nat Rev Cancer.
2005 Mar.
Abstract
Sophisticated genetic technologies have led to the development of mouse models of human cancers that recapitulate important features of human oncogenesis. Many of these genetically engineered mouse models promise to be very relevant and relatively rapid systems for determining the efficacy of chemopreventive agents and their mechanisms of action. The validation of such models for chemoprevention will help the selection of appropriate agents for large-scale clinical trials and allow the testing of combination therapies.
Similar articles
-
The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.Mutat Res. 2005 Aug 25;576(1-2):111-9. doi: 10.1016/j.mrfmmm.2005.02.012. Mutat Res. 2005. PMID: 15885713 Review.
-
Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.Eur J Cancer. 2004 Apr;40(6):858-80. doi: 10.1016/j.ejca.2003.11.031. Eur J Cancer. 2004. PMID: 15120042 Review.
-
The utility of genetically altered mouse models for nutrition and cancer chemoprevention research.Mutat Res. 2005 Aug 25;576(1-2):80-92. doi: 10.1016/j.mrfmmm.2004.11.019. Mutat Res. 2005. PMID: 15990122 Review.
-
Tailoring cancer chemoprevention regimens to the individual.J Cell Biochem. 2004 Feb 1;91(2):277-86. doi: 10.1002/jcb.20001. J Cell Biochem. 2004. PMID: 14743388 Review.
-
Molecular genetic alterations as intermediate end points in chemoprevention studies.IARC Sci Publ. 1996;(139):249-60. IARC Sci Publ. 1996. PMID: 8923035 Review.
Cited by
-
Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17396-401. doi: 10.1073/pnas.0608607103. Epub 2006 Nov 7. Proc Natl Acad Sci U S A. 2006. PMID: 17090666 Free PMC article.
-
Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.Oncoimmunology. 2013 Sep 1;2(9):e26137. doi: 10.4161/onci.26137. Epub 2013 Sep 12. Oncoimmunology. 2013. PMID: 24228231 Free PMC article.
-
The untapped potential of genetically engineered mouse models in chemoprevention research: opportunities and challenges.Cancer Prev Res (Phila). 2008 Aug;1(3):161-6. doi: 10.1158/1940-6207.CAPR-08-0076. Cancer Prev Res (Phila). 2008. PMID: 19138951 Free PMC article. Review.
-
Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth.Mol Imaging Biol. 2013 Apr;15(2):175-85. doi: 10.1007/s11307-012-0588-5. Mol Imaging Biol. 2013. PMID: 22875335 Free PMC article.
-
Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective Breast Cancer Detection in a Mucin-1 Transgenic Murine Mouse Model.J Biomed Nanotechnol. 2016 Dec;12(12):2172-2184. doi: 10.1166/jbn.2016.2318. J Biomed Nanotechnol. 2016. PMID: 28522938 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
